MAP4K3 and non-small cell lung carcinoma: The association between the recurrence-free survival rates and GLK protein levels was higher than that between the recurrence-free survival rates and the pathologic stages (HR = 2.11, 95% CI, 0.90–4.97, P = 0.087; Table 3) in NSCLC patients.